SIR, We read with interest the article by Dawes et al which describes a case of gonococcal arthritis presenting as pseudothrombophlebitis. ' We have recently observed the pseudothrombophlebitic onset of septic arthritis in a patient with systemic lupus erythematosus (SLE).
The patient was a 34 year old woman with a 10 year history of SLE which was controlled with prednisone 20 mg daily. Six days before admission she experienced fever, polyarthralgia, and a swollen right knee. It is difficult to decide for whom this book has been written. Structural formulae abound and much of each chapter is concerned with the chemistry and pharmacokinetics of individual drugs, yet the approach is altogether too superficial for the serious student of pharmacology. On the other hand, detailed descriptions of drugs not yet generally available (auranofin) or recently withdrawn from sale (fenclofenac) are unlikely to be of great interest to the practising rheumatologist. There are several areas of inaccuracy (e.g., the physiology of the hypothalamicadrenal axis) and some of inadequate content (e.g., renal effects of non-steroidal anti-inflammatory drugs); the units used are American (e.g., mg/dl) and not English.
Although several weighty and highly expensive textbooks on anti-inflammatory drugs have been published recently, there remains a need for a short, accurate, and well referenced resume of currently used drugs. Unfortunately this book does not fulfil that need.
